Your browser doesn't support javascript.
loading
MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner.
Castell, Alina; Yan, Qinzi; Fawkner, Karin; Bazzar, Wesam; Zhang, Fan; Wickström, Malin; Alzrigat, Mohammad; Franco, Marcela; Krona, Cecilia; Cameron, Donald P; Dyberg, Cecilia; Olsen, Thale Kristin; Verschut, Vasiliki; Schmidt, Linnéa; Lim, Sheryl Y; Mahmoud, Loay; Hydbring, Per; Lehmann, Sören; Baranello, Laura; Nelander, Sven; Johnsen, John Inge; Larsson, Lars-Gunnar.
Affiliation
  • Castell A; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Yan Q; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Fawkner K; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Bazzar W; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Zhang F; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Wickström M; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Alzrigat M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Franco M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Krona C; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Cameron DP; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
  • Dyberg C; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Olsen TK; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Verschut V; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Schmidt L; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Lim SY; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Mahmoud L; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Hydbring P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Lehmann S; Department of Medicine, Karolinska University Hospital, Huddinge, Sweden.
  • Baranello L; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
  • Nelander S; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Johnsen JI; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Larsson LG; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Cancer Res Commun ; 2(3): 182-201, 2022 03.
Article in En | MEDLINE | ID: mdl-36874405
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroblastoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Commun Year: 2022 Document type: Article Affiliation country: Sweden Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroblastoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Commun Year: 2022 Document type: Article Affiliation country: Sweden Country of publication: United States